Picalm Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PICALM (Phosphatidylinositol Binding Clathrin Assembly Protein), also known as CALM (Clathrin Assembly Lymphoid Myeloid leukemia protein), is a key regulator of clathrin-mediated endocytosis. Genetic variants in PICALM are associated with Alzheimer's disease risk. [1]
This page provides comprehensive information about the protein/gene, its function in the nervous system, and its role in neurodegenerative diseases. [2]
PICALM is a 652 amino acid cytosolic protein: [3]
PICALM is a key endocytic adaptor:
PICALM variants modulate AD risk:
| Strategy | Status | Notes |
|---|---|---|
| Endocytosis modulators | Research | Enhance protective pathways |
| PICALM enhancers | Discovery | Increase expression |
| Synaptic function | Preclinical | Indirect targeting |
| Gene therapy | Future | AAV delivery |
The study of Picalm Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cargo Selection: Selects synaptic vesicle proteins for incorporation. Cargo Selection. ↩︎ ↩︎
Coat Disassembly: Works with auxilin and Hsc70 for clathrin uncoating. Coat Disassembly. ↩︎
Synaptic Vesicle Pools: Regulates the size and replenishment of synaptic vesicle pools. Synaptic Vesicle Pools. ↩︎
Vesicle Formation: Facilitates clathrin coat assembly at the presynaptic membrane. Vesicle Formation. ↩︎